255 related articles for article (PubMed ID: 31846894)
1. Graphene aerogel nanoparticles for in-situ loading/pH sensitive releasing anticancer drugs.
Ayazi H; Akhavan O; Raoufi M; Varshochian R; Hosseini Motlagh NS; Atyabi F
Colloids Surf B Biointerfaces; 2020 Feb; 186():110712. PubMed ID: 31846894
[TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
[TBL] [Abstract][Full Text] [Related]
3. Understanding the co-loading and releasing of doxorubicin and paclitaxel using chitosan functionalized single-walled carbon nanotubes by molecular dynamics simulations.
Karnati KR; Wang Y
Phys Chem Chem Phys; 2018 Apr; 20(14):9389-9400. PubMed ID: 29565091
[TBL] [Abstract][Full Text] [Related]
4. pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin.
Yang S; Tang Z; Zhang D; Deng M; Chen X
Biomater Sci; 2017 Sep; 5(10):2169-2178. PubMed ID: 28914292
[TBL] [Abstract][Full Text] [Related]
5. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
[TBL] [Abstract][Full Text] [Related]
6. pH-sensitive polymeric micelles formed by doxorubicin conjugated prodrugs for co-delivery of doxorubicin and paclitaxel.
Ma Y; Fan X; Li L
Carbohydr Polym; 2016 Feb; 137():19-29. PubMed ID: 26686101
[TBL] [Abstract][Full Text] [Related]
7. Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment.
Gharehdaghi Z; Rahimi R; Naghib SM; Molaabasi F
J Biol Inorg Chem; 2021 Sep; 26(6):689-704. PubMed ID: 34420089
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
[TBL] [Abstract][Full Text] [Related]
9. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
Zhang B; Yang X; Wang Y; Zhai G
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
[TBL] [Abstract][Full Text] [Related]
10. pH-sensitive polyketal nanoparticles for drug delivery.
Wang Y; Chang B; Yang W
J Nanosci Nanotechnol; 2012 Nov; 12(11):8266-75. PubMed ID: 23421205
[TBL] [Abstract][Full Text] [Related]
11. Loading and release of cancer chemotherapy drugs utilizing simultaneous temperature and pH-responsive nanohybrid.
Dahri M; Akbarialiabad H; Jahromi AM; Maleki R
BMC Pharmacol Toxicol; 2021 Jul; 22(1):41. PubMed ID: 34261533
[TBL] [Abstract][Full Text] [Related]
12. Normalization of doxorubicin release from graphene oxide: New approach for optimization of effective parameters on drug loading.
Hashemi M; Yadegari A; Yazdanpanah G; Omidi M; Jabbehdari S; Haghiralsadat F; Yazdian F; Tayebi L
Biotechnol Appl Biochem; 2017 May; 64(3):433-442. PubMed ID: 26878983
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent graphene oxide via polymer grafting: an efficient nanocarrier for both hydrophilic and hydrophobic drugs.
Kundu A; Nandi S; Das P; Nandi AK
ACS Appl Mater Interfaces; 2015 Feb; 7(6):3512-23. PubMed ID: 25612470
[TBL] [Abstract][Full Text] [Related]
14. High drug loading and pH-responsive targeted nanocarriers from alginate-modified SPIONs for anti-tumor chemotherapy.
Peng N; Wu B; Wang L; He W; Ai Z; Zhang X; Wang Y; Fan L; Ye Q
Biomater Sci; 2016 Nov; 4(12):1802-1813. PubMed ID: 27792228
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
16. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
[TBL] [Abstract][Full Text] [Related]
17. Design and Development of Graphene Oxide Nanoparticle/Chitosan Hybrids Showing pH-Sensitive Surface Charge-Reversible Ability for Efficient Intracellular Doxorubicin Delivery.
Zhao X; Wei Z; Zhao Z; Miao Y; Qiu Y; Yang W; Jia X; Liu Z; Hou H
ACS Appl Mater Interfaces; 2018 Feb; 10(7):6608-6617. PubMed ID: 29368916
[TBL] [Abstract][Full Text] [Related]
18. Biochemical characterization of the interactions between doxorubicin and lipidic GM1 micelles with or without paclitaxel loading.
Leonhard V; Alasino RV; Bianco ID; Garro AG; Heredia V; Beltramo DM
Int J Nanomedicine; 2015; 10():3377-87. PubMed ID: 26005348
[TBL] [Abstract][Full Text] [Related]
19. Tracking the intracellular drug release from graphene oxide using surface-enhanced Raman spectroscopy.
Huang J; Zong C; Shen H; Cao Y; Ren B; Zhang Z
Nanoscale; 2013 Nov; 5(21):10591-8. PubMed ID: 24057012
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
Metin E; Mutlu P; Gündüz U
Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
